End point: Hazard ratio 95% CI p-value
Clinically Significant QTc Prolongation (39 events) Clinically Significant QTc Prolongation (39 events) Clinically Significant QTc Prolongation (39 events) Clinically Significant QTc Prolongation (39 events)
Beta Blocker 3.5 1.04 – 12.3 0.042
Median QTc ≥ 450 during first hour post CV 2.2 0.92 – 5.2 0.093